In addition, we observed significantly decreased severity and a significant reduction in the diameter (18%, P = 0.011) of AAA in angiotensin II-infused CTLA-4-Tg/Apoe−/− mice (Fig. 1E,F). The gene discussed is CTLA4; the disease is triple-A syndrome.